Asarfi Hospital Limited · BSE:ASARFI

Asarfi Hospital — Q2 FY27 Earnings Presentation

27 slides from Asarfi Hospital's earnings presentation, Nov 13, 2026

  1. Slide 1: Submission of Investor Presentation to BSE

    असफ हॉ ीटल सबके िलए ा AHL/AO/2026/1467 Date: 13.11.2026 To, The Listing Department BSE Limited 25th Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Subject: Submission of Investor Presentation. Ref: Scrip Code: 543943 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obl

  2. Slide 2: Investor Presentation Q2'FY27

    ASARFI HOSPITAL LIMITED Investor Presentation Q2’FY27 Leading Healthcare Provider in Eastern India 20+ 350 BSE SME Years of care Beds across 2 units Scrip 543943 Trust | Quality | Care

  3. Slide 3: Disclaimer

    Disclaimer Certain matters discussed in this presentation may contain statements regarding the company's market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements do not guarantee future performance and are subject to

  4. Slide 4: Agenda

    Agenda 01 02 03 Q2’FY27 Highlights Quarterly Updates Asarfi Hospital At A Glance • Financial snapshot and P&L summary • Clinical conclaves and CME programmes • Overview, journey and departments • Revenue mix by specialty • Physician and referral outreach • Infrastructure and technology • IPD-OPD, AR

  5. Slide 5: Q2'FY27 Highlights

    01 Q2’FY27 Highlights Asarfi Hospital Limited | Investor Presentation Q2’FY27

  6. Slide 6: Q2'FY27: A Record-Breaking Quarter

    Q2’FY27: A Record-Breaking Quarter Highest-ever quarterly revenue, EBITDA, EBIT and PAT | Highest-ever EBITDA margin at 22.4% H I G H E ST E V E R H I G H E ST E V E R H I G H E ST E V E R H I G H E ST E V E R ₹53.0 Cr ₹11.9 Cr 22.4% ₹6.1 Cr Quarterly Revenue Quarterly EBITDA EBITDA Margin Quarterly

  7. Slide 7: Quarterly Snapshot – Q2'FY27

    Quarterly Snapshot – Q2’FY27 FINANCIAL PERFORMANCE (CONSOLIDATED) Revenue EBITDA EBITDA Margin EBIT PAT PAT Margin ₹53.0 Cr ₹11.9 Cr 22.4% ₹9.5 Cr ₹6.1 Cr 11.5% ▲ +18.1% YoY ▲ +34.0% YoY ▲ +41.6% YoY ▲ +45.2% YoY +11.6% QoQ | vs ₹44.9 Cr +25.7% QoQ | vs ₹8.9 Cr vs 19.8% in Q2’FY26 Margin 17.9% (vs 1

  8. Slide 8: Quarterly Profit and Loss Summary

    Quarterly Profit and Loss Summary Standalone (₹ in Lakhs) Consolidated (₹ in Lakhs) Particulars Q2’FY26 Q1’FY27 Q2’FY27 QoQ % YoY % Particulars Q2’FY26 Q1’FY27 Q2’FY27 QoQ % YoY % Revenue from operations 4,485 4,734 5,287 11.7% 17.9% Revenue from operations 4,489 4,753 5,304 11.6% 18.1% Material cos

  9. Slide 9: Quarterly Highlights – Standalone

    Quarterly Highlights – Standalone IPD-OPD Revenues (₹ in Lakhs) IPD ~17% YoY Revenue Growth YoY EBITDA Margin 4,400 17.9% 22.5% 3,773 to ₹53 Cr (vs ₹45 Cr in Q2’FY26) vs 19.9% in Q2’FY26 887 EBIT Margin PAT Margin 637 18.1% 11.6% Q2’FY26 Q2’FY27 vs 15.2% in Q2’FY26 vs 9.6% in Q2’FY26 IPD Revenues OP

  10. Slide 10: Key Financial Parameters – Standalone

    Key Financial Parameters – Standalone Revenue (₹ in Lakhs) +17.9% YoY EBITDA (₹ in Lakhs) & Margin +33.5% YoY 1,190 5,287 4,485 4,734 891 942 Q2’FY26 Q1’FY27 Q2’FY27 Q2’FY26 Q1’FY27 Q2’FY27 Margin 19.9% 19.9% 22.5% EBIT (₹ in Lakhs) & Margin +40.1% YoY PAT (₹ in Lakhs) & Margin +42.7% YoY 956 614 68

  11. Slide 11: Key Financial Parameters – Consolidated

    Key Financial Parameters – Consolidated Revenue (₹ in Lakhs) +18.1% YoY EBITDA (₹ in Lakhs) & Margin +34.0% YoY 1,189 5,304 4,753 887 946 4,489 Q2’FY26 Q1’FY27 Q2’FY27 Q2’FY26 Q1’FY27 Q2’FY27 Margin 19.8% 19.9% 22.4% EBIT (₹ in Lakhs) & Margin +41.6% YoY PAT (₹ in Lakhs) & Margin +45.2% YoY 951 609

  12. Slide 12: Revenue Mix – Super-Specialty Hospital Unit

    Revenue Mix – Q2’FY27 vs Q2’FY26 Super-Specialty Hospital Unit Q2’FY27 YoY Revenue Growth by Specialty Cardiology 14% General Medicine 12% Neurosciences 42% General Surgery -2% Q2’FY26 Q2’FY27 Paediatrics & Neonatology 78% ₹32.2 Cr ₹41.3 Cr Orthopaedics 37% Obstetrics & Gynaecology 41% Gastroenterol

  13. Slide 13: Revenue Mix – Cancer Hospital Unit

    Revenue Mix – Q2’FY27 vs Q2’FY26 Cancer Hospital Unit Q2’FY27 YoY Revenue Growth by Specialty Medical Oncology 4% Surgical Oncology -56% Radiation Oncology -18% Q2’FY26 Q2’FY27 ₹11.9 Cr ₹11.6 Cr Head and Neck Oncology 43% Haemato Oncology 46% Others* 86% Specialty Q2’FY26 Q2’FY27 Medical Oncology 54

  14. Slide 14: IPD-OPD Highlights (Both Hospital Units)

    IPD-OPD Highlights (Both Hospital Units) Patient Volumes Revenues (₹ in Lakhs) Inpatient (IPD) Outpatient (OPD) IPD Revenues OPD Revenues QoQ +5% YoY +13% QoQ +12% YoY +25% QoQ +12% YoY +17% QoQ +18% YoY +39% 4,429 41,285 4,400 887 4,236 3,930 36,958 3,773 3,935 753 32,955 637 Q2’FY26 Q1’FY27 Q2’FY2

  15. Slide 15: Unit-wise ARPOB, Bed Capacity and Occupancy

    Unit-wise ARPOB, Bed Capacity and Occupancy ARPOB (₹) YoY +17% QoQ +1% Occupancy % (bed capacity) Key observations • Occupancy recovered to 64% from 23,498 23,716 Super-Specialty 64% 64% 59% in Q1’FY27 20,247 59% Hospital Unit • ARPOB up 17% YoY and 1% QoQ to ₹23,716 • Capacity expanded to 285 beds

  16. Slide 16: Surgery Count

    Surgery Count Total Surgeries Specialty-wise Surgeries Q2’FY26 Q1’FY27 Q2’FY27 YoY +25% QoQ +16% Cardiology 488 431 483 Gastroenterology 546 460 419 2,295 General Surgery 201 191 159 1,980 Obstetrics & Gynaecology 190 248 206 1,831 Orthopaedics 144 139 106 Neurology 81 55 66 Burn & Plastic Surgery 6

  17. Slide 17: Quarterly Updates

    02 Quarterly Updates Asarfi Hospital Limited | Investor Presentation Q2’FY27

  18. Slide 18: Key Quarterly Updates

    Key Quarterly Updates What drove the business in Q2’FY27 (July – September 2026) Strong Doctor Connect Wider Promotional Reach 01 Connect with 1,500 doctors across Jharkhand and parts 02 Promotional coverage expanded from 7 districts to 10 of West Bengal, driving referrals districts Insurance Tie-up

  19. Slide 19: Asarfi Hospital At A Glance

    03 Asarfi Hospital At A Glance Asarfi Hospital Limited | Investor Presentation Q2’FY27

  20. Slide 20: Leading Healthcare Player in Jharkhand

    Asarfi Hospital: Leading Healthcare Player in Jharkhand Healthcare Excellence Since 2005 Serving Dhanbad and neighbouring areas for 20+ years with affordable, best-in- class healthcare, operating two hospitals with 350 total beds across Super- Specialty and Cancer Care units. First and Only in the R

  21. Slide 21: Journey Over the Years

    Journey Over the Years 2005 2008 2016 2017 2022 2023 2024 2025 2026 Incorporation IPD Dept Expansion Phase 1 Expansion Phase 2 Cancer hospital IPO Cancer hospital Strategic partnership Tech upgradation construction operational 2025 – 2026 & Beyond: Partnerships 2005 – 2009: Foundation 2016 – 2024: E

  22. Slide 22: Our Departments

    Our Departments Paediatrics & Obstetrics & Cardiology Neurosciences General Medicine General Surgery Neonatology Gynaecology Burn & Plastic Gastroenterology Orthopaedics Oncology Nephrology Urology Surgery Ophthalmology ENT Day Care Services Dental Sciences Physiotherapy Emergency Nutrition & Anaest

  23. Slide 23: Backed by Cutting-Edge Infrastructure and Facilities

    Backed by Cutting-Edge Infrastructure and Facilities Super Specialty Hospital, Dhanbad Varian TrueBeam Jharkhand’s 1st and most advanced radiation 285 ₹23,716 64% 4.6 Days machine – precision cancer care, advanced Beds ARPOB Occupancy ALOS imaging & tracking and faster treatment delivery. • Establis

  24. Slide 24: Delivering Consistent Shareholder Returns

    Delivering Consistent Shareholder Returns Stock Info Share Price History (₹) BSE Scrip Code SME: 543943 Shares Outstanding 1,96,77,300 +85% since listing +21% CAGR in ~3 years 52-Week Range (₹) 135 – 257 250 Free Float (%) 38.83% Market Cap (₹ Cr)* 342 EPS (₹) (TTM) 10.01 200 Net D/E (Sep 2026) 0.45

  25. Slide 25: Competitive Strengths

    Competitive Strengths Regional Advantage 30 Lakh+ Eastern India • Eastern India offers a compelling opportunity – low penetration of organised hospital Population served chains, high population density and rising insurance adoption • 1 of only 3 cancer hospitals in Jharkhand, enabling regional refer

  26. Slide 26: Leadership Team

    Leadership Team Harendra Singh Udai Pratap Singh Sukanti Kumar Das Promoter & CFO Promoter & MD Non-Executive Director • A visionary entrepreneur inspired by the Company’s • Started his career in 2017; process- and system-driven, • Renowned consultant gynaecologist with over 35 years purpose – Healt

  27. Slide 27: Thank You

    Thank You CONTACT DETAILS Mr. Udai Pratap Singh Managing Director (MD) Contact No.: +91 96088 33708 Email: cs@asarfihospital.com Web: www.asarfi.in ASARFI HOSPITAL LIMITED | Baramuri, B Polytechnic, Dhanbad, Jharkhand 828130 | CIN: L85110JH2005PLC011673

Asarfi Hospital — Q2 FY27 Earnings Presentation on 6ix